Subscribe
shutterstock_1425318470_photobyphm
Photobyphm / Shutterstock.com
29 August 2019AmericasRory O'Neill

US court backs Sanofi and Regeneron in Amgen suit

A US judge yesterday, August 28 ruled in favour of Sanofi and Regeneron in the pharmaceutical companies’ long-running patent dispute with Amgen over the cholesterol drug Praluent.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Big Pharma
Regeneron asks court to dismiss COVID-19 tech patent suit
24 August 2021   Regeneron wants a Manhattan district court to toss a lawsuit that claims it infringed on patents in the development and testing of COVID-19 treatments.
Big Pharma
German court deals blow to Sanofi over cholesterol drug
5 June 2019   A German court has rejected a bid from French pharmaceutical company Sanofi to have a patent infringement case dismissed.


Editor's picks

UKIPO rejects Boehringer’s SPC for horse inhaler
Americas
UKIPO rejects Boehringer’s SPC for horse inhaler
8 July 2025

Editor's picks

Americas
UKIPO rejects Boehringer’s SPC for horse inhaler
8 July 2025
Americas
Bankruptcy judge approves $305m sale of genetics testing company
1 July 2025
Americas
A step too far? Why Stewart’s approach is dividing opinion
24 June 2025
Europe
Diverging in the detail: UPC local divisions and Court of Appeal take different paths
19 June 2025
Europe
UPC confirms permanent injunction against Curio in 10x tech dispute
17 June 2025
Americas
LSPN: In-house ‘chess game’ is the same, but the rules have changed
9 May 2025

More on this story

Big Pharma
Regeneron asks court to dismiss COVID-19 tech patent suit
24 August 2021   Regeneron wants a Manhattan district court to toss a lawsuit that claims it infringed on patents in the development and testing of COVID-19 treatments.
Big Pharma
German court deals blow to Sanofi over cholesterol drug
5 June 2019   A German court has rejected a bid from French pharmaceutical company Sanofi to have a patent infringement case dismissed.

More on this story

Big Pharma
Regeneron asks court to dismiss COVID-19 tech patent suit
24 August 2021   Regeneron wants a Manhattan district court to toss a lawsuit that claims it infringed on patents in the development and testing of COVID-19 treatments.
Big Pharma
German court deals blow to Sanofi over cholesterol drug
5 June 2019   A German court has rejected a bid from French pharmaceutical company Sanofi to have a patent infringement case dismissed.

More features

UKIPO rejects Boehringer’s SPC for horse inhaler
WilmerHale gains partner with ‘deep expertise’
Bayer, Orion take on Indian generic over $117bn drug
‘We created law’: G1/24 and the creation of the ‘diamond standard’
BMS unit loses cell therapy patent at European Patent Office
Amgen sues Biocon over blockbuster bone drugs as first biosimilars enter market
Lord Justice Birss to become chancellor of the High Court
Bankruptcy judge approves $305m sale of genetics testing company